Cancer Research Technology
Log in Register
Menu

MDA-MB-231 CAGA12-Luc/TK Renilla cell line

Invented by Caroline Hill at The Francis Crick Institute

Info

Catalogue Number 156437
Antigen/Gene or Protein Targets Activin and transforming growth factor β (TGF-β) signalling
Parental Line MDA-MB-231 cell line
Host Human
Tissue Breast
Disease Keywords Breast cancer
Model Reporter
Relevance The human breast cancer cell line MDA-MB-31 modified for use as a reporter cell line for Activin and TGF-beta signalling. The cell line stably expresses CAGA12-Luc, a Smad3/Smad4-dependent reporter containing 12 copies of the CAGAC sites (AGAC motif underlined) from the PAI-1 promoter. This is a Smad3/Smad4-dependent reporter, although it also binds complexes of Smad2 exon 3 with Smad4. The cell line also contains a Renilla reporter driven by the thymidine kinase (TK) promoter to act as an internal control.
Production Details Made by transfecting the breast cancer cell line MDA-MB-231 with CAGA12-Luc with pRetroSuper for puromycin resistance and then TK Renilla with pCMV-Bsd for blasticidin resistance.Clonal
Conditional Description In the presence of activin and TGF-beta signalling luciferase is expressed.
Research Area Cancer, Cell Signaling & Signal Transduction, Developmental Biology
Recommended Growing Conditions Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS)+ 50 µg/ml blasticidin

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Grönroos et al. 2012. Mol Cell Biol. 32(14):2904-16. PMID: 22615489.


Add a reference

References: 1 entry

Grönroos et al. 2012. Mol Cell Biol. 32(14):2904-16. PMID: 22615489.


Add a reference

Inventor Information